LD-2 disclosure · 3rd Quarter - Report
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Client
- Description
- Informal coalition of health and consumer organizations and sunscreen industry companies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
LobbyistsJOEL ROBERSON · MICHAEL WERNER · PARKER REYNOLDS · ABIGAIL HEMENWAY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)